Literature DB >> 31408176

Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity.

Kelli A Lytle1, Nikki C Bush1, Jessica M Triay1, Todd A Kellogg2, Michael L Kendrick2, James M Swain2, Nicola W Gathaiya1, Kazanna C Hames1, Michael D Jensen1.   

Abstract

OBJECTIVE: Nonalcoholic fatty liver disease can lead to hepatic inflammation/damage. Understanding the physiological mechanisms that contribute to excess hepatic lipid accumulation may help identify effective treatments.
DESIGN: We recruited 25 nondiabetic patients with severe obesity scheduled for bariatric surgery. To evaluate liver export of triglyceride fatty acids, we measured very-low-density lipoprotein (VLDL)-triglyceride secretion rates the day prior to surgery using an infusion of autologous [1-14C]triolein-labeled VLDL particles. Ketone body response to fasting and intrahepatic long-chain acylcarnitine concentrations were used as indices of hepatic fatty acid oxidation. We measured intraoperative hepatic uptake rates of plasma free fatty acids using a continuous infusion of [U-13C]palmitate, combined with a bolus dose of [9,10-3H]palmitate and carefully timed liver biopsies. Total intrahepatic lipids were measured in liver biopsy samples to determine fatty liver status. The hepatic concentrations and enrichment from [U-13C]palmitate in diacylglycerols, sphingolipids, and acyl-carnitines were measured using liquid chromatography/tandem mass spectrometry.
RESULTS: Among study participants with fatty liver disease, intrahepatic lipid was negatively correlated with VLDL-triglyceride secretion rates (r = -0.92, P = 0.01) but unrelated to hepatic free fatty acid uptake or indices of hepatic fatty acid oxidation. VLDL-triglyceride secretion rates were positively correlated with hepatic concentrations of saturated diacylglycerol (r = 0.46, P = 0.02) and sphingosine-1-phosphate (r = 0.44, P = 0.03).
CONCLUSION: We conclude that in nondiabetic humans with severe obesity, excess intrahepatic lipid is associated with limited export of triglyceride in VLDL particles rather than increased uptake of systemic free fatty acids.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31408176      PMCID: PMC6821207          DOI: 10.1210/jc.2019-00875

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

3.  Role of ceramides in nonalcoholic fatty liver disease.

Authors:  Mangesh Pagadala; Takhar Kasumov; Arthur J McCullough; Nizar N Zein; John P Kirwan
Journal:  Trends Endocrinol Metab       Date:  2012-05-17       Impact factor: 12.015

4.  Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.

Authors:  Chrysi Koliaki; Julia Szendroedi; Kirti Kaul; Tomas Jelenik; Peter Nowotny; Frank Jankowiak; Christian Herder; Maren Carstensen; Markus Krausch; Wolfram Trudo Knoefel; Matthias Schlensak; Michael Roden
Journal:  Cell Metab       Date:  2015-05-05       Impact factor: 27.287

5.  Simultaneous determination of molecular species of monoacylglycerols, diacylglycerols and triacylglycerols in human very-low-density lipoproteins by reversed-phase liquid chromatography.

Authors:  Javier S Perona; Valentina Ruiz-Gutierrez
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-02-25       Impact factor: 3.205

6.  Heat leakage across the abdominal wall and meal-induced thermogenesis in normal-weight and obese subjects.

Authors:  T Brundin; A Thörne; J Wahren
Journal:  Metabolism       Date:  1992-01       Impact factor: 8.694

7.  Validation of a new method for determination of free fatty acid turnover.

Authors:  J M Miles; M G Ellman; K L McClean; M D Jensen
Journal:  Am J Physiol       Date:  1987-03

8.  Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects.

Authors:  Jason M R Gill; Jacqueline C Brown; Dorothy Bedford; Dawn M Wright; Josephine Cooney; David A Hughes; Chris J Packard; Muriel J Caslake
Journal:  Atherosclerosis       Date:  2004-09       Impact factor: 5.162

9.  Contribution of very low-density lipoprotein triglyceride fatty acids to postabsorptive free fatty acid flux in obese humans.

Authors:  Nikki C Bush; Jessica M Triay; Nicola W Gathaiya; Kazanna C Hames; Michael D Jensen
Journal:  Metabolism       Date:  2013-10-17       Impact factor: 8.694

10.  Free fatty acid uptake in humans with CD36 deficiency.

Authors:  Kazanna C Hames; Adrian Vella; Bradley J Kemp; Michael D Jensen
Journal:  Diabetes       Date:  2014-06-10       Impact factor: 9.461

View more
  5 in total

Review 1.  A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes.

Authors:  Amy E Rumora; Bhumsoo Kim; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2022-04-26       Impact factor: 7.468

Review 2.  Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.

Authors:  Mojgan Masoodi; Amalia Gastaldelli; Tuulia Hyötyläinen; Enara Arretxe; Cristina Alonso; Melania Gaggini; Julia Brosnan; Quentin M Anstee; Oscar Millet; Pablo Ortiz; Jose M Mato; Jean-Francois Dufour; Matej Orešič
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-10       Impact factor: 46.802

3.  Adipocyte Proteins and Storage of Endogenous Fatty Acids in Visceral and Subcutaneous Adipose Tissue in Severe Obesity.

Authors:  Kelli A Lytle; Nikki C Bush; Jessica M Triay; Todd A Kellogg; Michael L Kendrick; James M Swain; Nicola W Gathaiya; Kazanna C Hames; Michael D Jensen
Journal:  Obesity (Silver Spring)       Date:  2021-04-24       Impact factor: 9.298

Review 4.  Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease.

Authors:  Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  J Dev Orig Health Dis       Date:  2020-04-15       Impact factor: 2.401

Review 5.  Metabolic-associated fatty liver disease and lipoprotein metabolism.

Authors:  Joerg Heeren; Ludger Scheja
Journal:  Mol Metab       Date:  2021-04-20       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.